baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC Call 55 FPE3 17.12.2025/ DE000HS5Z0S9 /

2024-05-31 8:37:12 AM	Chg.+0.015	Bid10:00:11 PM	Ask10:00:11 PM	Underlying	Strike price	Expiration date	Option type
0.184EUR	+8.88%	- Bid Size: -	- Ask Size: -	FUCHS SE VZO NA O.N...	55.00 EUR	2025-12-17	Call

TeleTrader 4:16 PM Belgium condemns Israel's bid to label UNRWA as terrorist

GlobeNewswire 4:00 PM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstr...

GlobeNewswire 4:00 PM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...

GlobeNewswire 4:00 PM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...

TeleTrader 3:23 PM Macron backs Biden's ceasefire proposal for Gaza

GlobeNewswire 3:14 PM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing

GlobeNewswire 3:00 PM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Ther...

GlobeNewswire 3:00 PM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monothera...

TeleTrader 2:35 PM ANC loses 30-year majority in S. Africa

GlobeNewswire 2:15 PM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with ...

GlobeNewswire 2:15 PM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting

GlobeNewswire 2:05 PM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting

GlobeNewswire 2:00 PM Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages...

GlobeNewswire 2:00 PM Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonst...

GlobeNewswire 2:00 PM Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin)...

GlobeNewswire 2:00 PM OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform

GlobeNewswire 2:00 PM Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at...

GlobeNewswire 2:00 PM CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes

GlobeNewswire 2:00 PM Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confi...

GlobeNewswire 1:55 PM ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors...

TeleTrader 1:41 PM Netanyahu: Ceasefire tied to Hamas dismantling

GlobeNewswire 1:00 PM Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...

TeleTrader 12:43 PM Gaza Health Ministry: Death toll rises to 36,379

TeleTrader 11:49 AM Indonesia's Prabowo ready to send peacekeepers to Gaza

GlobeNewswire 11:42 AM VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to...

HSBC Call 55 FPE3 17.12.2025/ DE000HS5Z0S9 /

If you wish to receive reply to your feedback, please provide your email address.